The European Commission has released figures showing that there has
been a dramatic and concerning increase in pharmaceutical
counterfeiting, with seizures in Europe hitting an all time high of
over 2.5m items.
A magic bullet for the pharmaceutical supply chain has entered the
stage as radio frequency identification (RFID) technology attempts
to fix up its teething problems.
MDS Pharma has decided to continue the 'consolidation' of its
Canadian operations by putting an end to some activities at its
Montreal facility, cutting 160 jobs.
The latest ethical reputations of the world's largest
pharmaceutical companies have been revealed, with GlaxoSmithKline
(GSK) emerging as big pharma's Mother Theresa, according to a
recently-released compilation by Geneva-based...
CellCyte Genetics, Whatman, Nektar Therapeutics, Anesiva and
Hyaluron Contract Manufacturing have all had people on the move in
the world of pharmaceutical manufacturing.
Batches of two fake blockbuster drugs are being recalled after
counterfeits made their way into the UK supply chain via parallel
distribution, adding fuel to the debate on the security of the
practice in the EU.
Albany Molecular Research (AMRI) has followed up its push into new
markets for its drug discovery operations by tapping into the
well-established trend for sourcing contract pharmaceutical
manufacturing from the lower-cost Asian region.
Thailand is the first recipient of six major grants the World
Health Organization (WHO) is distributing to developing countries
to establish in-country manufacturing capacity for influenza
vaccine.
A UK-based technology company is part of a trio leading the way in
innovative supply chain solutions by combining real-time
temperature monitoring with a radio frequency identification (RFID)
tag for the pharmaceutical industry.
The critical role transgenic animals could play in the future of
biopharmaceutical production has been tackled by a task force in a
new report out this week.
There are some areas of the European approval system
for biosimilars that still need to be clarified, a panel of
industry experts said during BIO 2007.
A transdermal patch for needle-free delivery of insulin and a
diagnostic test for rapid detection of meningococcal disease are
among the products under development by two new Australian
companies set up to commercialise the research...
An online database detailing information on all manufacturing and
importation certificates and authorisations issued within the
European medicines network has been launched by the European
Medicines Agency (EMEA).
Indian biopharmaceutical company Wockhardt Limited has continued
its push into Europe with the all-cash acquisition of France's
Negma Laboratories (Negma-Lerads) for $265m (€195.4m).
One-off costs related to last year's acquisition of Serologicals
and a continuing manufacturing consolidation strategy were largely
responsible for sharp falls in Millipore's pre-tax and net profits
for the first quarter...
The US Biotechnology Industry Organisation (BIO) has fuelled even
further the ongoing debate over the potential approval path for
follow-on biologics in the country with the release of a white
paper this week that stressed that 'generic'...
West Pharmaceutical Services reported a 40 per cent increase in
operating profit for the first quarter of 2007, despite profits
diving 43 per cent in the Tech Group business that makes the
delivery device for Pfizer's inhaled...
Roche gave an update on its manufacturing of influenza drug Tamiflu
(oseltamivir) today, saying that while it had reached its target
capacity of 400 million doses a year, demand is running much lower.
Pfizer has shunned a more traditional approach to data management
outsourcing by slashing its vendors to a handful and standardising
them under the one business model.
Biovitrum, China Biopharma, Molecular Insight Pharmaceuticals,
Pipex Pharma and CH2M Hill have all had people on the move in the
world of pharmaceutical manufacturing.
Sanofi-Aventis' H5N1 bird flu vaccine has won approval from the US
Food and Drug Administration (FDA) as a limited protection measure
in case of a pandemic.
While the market performance of Exubera may have fallen short of
expectations, Pfizer's inhaled insulin has opened the door for a
wider variety of macromolecules to take the pulmonary delivery
route.
The European Union's (EU) member states must take their
responsibilities to implement the biotech policy proposed by the
European Commission (EC), said EuropaBio, the EU industry body.
Octagon has bought an electronic data capture (EDC) company and is
now claiming to be the first company to address the process problem
in clinical R&D by offering "an end-to-end solution that
crosses traditional functional...
Contract logistics provider Kuehne + Nagel (K+N) has announced it
is expanding its capacity in Dubai in a bid to provide a global hub
for pharmaceutical companies.
As Swiss firm Lonza announced last week that it has broken ground
at its second manufacturing site in Singapore, the region looks set
for growth in biologics manufacture with biological products due to
take centre stage in the pharma...
GlaxoSmithKline (GSK) has announced plans to outsource all its data
management and medical trial and regulatory reporting functions to
India in a deal said to be worth over £10m (€14.7m).
The US Food and Drug Administration (FDA) has tackled escalating
concerns about the independence of its advisory committees by
proposing more stringent criteria for avoiding potential conflicts
of interest when considering potential...
The demand for international assistance in recruitment processes
from pharmaceutical companies is set to boom in the next 12 months,
according to an industry player.
The European Parliament has backed proposed legislation to impose
hefty fines and penalties on criminals taking part in piracy and
counterfeiting activities.
Albany Molecular Research, Ranbaxy Laboratories, IBS Pharma, PhRMA
and Globalpharma have all had people on the move in the world of
pharmaceutical manufacturing.
A potential new law mandating the running of clinical trials before
a "generic" biologic drug approval may seem like a potential
goldmine for contract research organisations (CROs), however, this
vision is premature.
In-PharmaTechnologist.com and Outsourcing-Pharma.com journalist
Kirsty Barnes has received the honour of being announced among the
place winners of the 2006 Awards for Excellence in Health Care
Journalism (AHCJ).
In-PharmaTechnologist takes an indepth look at the new radio
frequency identification (RFID) technology that will soon
revolutionise pharmaceutical supply chain management.
The burgeoning Japanese pharmaceutical market is set to boost the
third party logistics (3PL) sector as drug makers are expected to
increase their reliance on outsourcing for this type of services in
the future, a new report said.
GlaxoSmithKline (GSK) has acquired licensing rights outside the US
to the over the counter (OTC) weight-loss medication orlistat,
previously marketed by Roche.
Dyax announced that it has reached a mutual agreement with Genzyme
to terminate their joint venture for the development and
commercialization of DX-88 for hereditary angioedema (HAE).
Movianto has more than doubled its pharmaceutical storage capacity
at two of its European sites with the construction of two new
warehouses, in answer to increased demand.
